Cannabidiol Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End Use (Medical, Personal Use, Pharmaceuticals, Wellness), By Region, And Segment Forecasts, 2026 - 2033
Description
Cannabidiol Market Summary
The global cannabidiol market size was estimated at USD 10.68 billion in 2025 and is projected to reach USD 30.96 billion by 2033, growing at a CAGR of 13.70% from 2026 to 2033. The market growth is driven by increasing consumer awareness of the potential therapeutic benefits of cannabidiol (CBD) for conditions such as chronic pain, anxiety, insomnia, and inflammation, coupled with a growing preference for natural and plant-based wellness solutions.
Expanding product diversification across oils, topicals, edibles, and pharmaceuticals is also supporting market uptake. In addition, evolving regulatory frameworks, rising investments in clinical research, and the broader retail availability of products from pharmacies to e-commerce are accelerating adoption in the cannabidiol industry.
The market is expected to grow with the increasing legalization of hemp-based products. Companies are developing a variety of cannabidiol products, including edibles, topicals, and beverages, to meet the demand from consumers. The rise of e-commerce has enabled companies to reach a broader audience and boost sales through online channels. For instance, in March 2025, Edible Brands, the parent company of Edible (formerly Edible Arrangements), introduced Edibles.com, a wellness-oriented e-commerce platform that offers same-day delivery of reliable THC-infused products from top brands, including Cann, Wana, and 1906.
In addition, growing interest in the potential health benefits of cannabidiol has led to increased investment in research and development to understand its effects better and develop new products. The cannabidiol market is becoming more competitive, with a growing number of companies entering the market and offering similar products.
Growing recognition of the therapeutic benefits of cannabidiol has driven consumers to purchase these products, even if they are expensive. As a result, commercial retailers are now focusing on selling cannabis-based items, which have a higher profit margin. For instance, Abercrombie & Fitch-a clothing retailer-plans to sell CBD-infused body care products in more than 160 of its 250-plus stores. Many health and wellness stores, such as Walgreens Boots Alliance, CVS Health, and Rite Aid, now offer CBD-based products. CBD is a non-psychoactive compound found in the hemp plant and is used in various forms, such as cream, edibles, oils, and tinctures. It is marketed for its potential health benefits, such as reducing anxiety and pain. It has seen a surge in demand due to the increasing legalization and normalization of marijuana and hemp-based products.
Global Cannabidiol Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cannabidiol market report based on source type, sales type, end use, and region:
The global cannabidiol market size was estimated at USD 10.68 billion in 2025 and is projected to reach USD 30.96 billion by 2033, growing at a CAGR of 13.70% from 2026 to 2033. The market growth is driven by increasing consumer awareness of the potential therapeutic benefits of cannabidiol (CBD) for conditions such as chronic pain, anxiety, insomnia, and inflammation, coupled with a growing preference for natural and plant-based wellness solutions.
Expanding product diversification across oils, topicals, edibles, and pharmaceuticals is also supporting market uptake. In addition, evolving regulatory frameworks, rising investments in clinical research, and the broader retail availability of products from pharmacies to e-commerce are accelerating adoption in the cannabidiol industry.
The market is expected to grow with the increasing legalization of hemp-based products. Companies are developing a variety of cannabidiol products, including edibles, topicals, and beverages, to meet the demand from consumers. The rise of e-commerce has enabled companies to reach a broader audience and boost sales through online channels. For instance, in March 2025, Edible Brands, the parent company of Edible (formerly Edible Arrangements), introduced Edibles.com, a wellness-oriented e-commerce platform that offers same-day delivery of reliable THC-infused products from top brands, including Cann, Wana, and 1906.
In addition, growing interest in the potential health benefits of cannabidiol has led to increased investment in research and development to understand its effects better and develop new products. The cannabidiol market is becoming more competitive, with a growing number of companies entering the market and offering similar products.
Growing recognition of the therapeutic benefits of cannabidiol has driven consumers to purchase these products, even if they are expensive. As a result, commercial retailers are now focusing on selling cannabis-based items, which have a higher profit margin. For instance, Abercrombie & Fitch-a clothing retailer-plans to sell CBD-infused body care products in more than 160 of its 250-plus stores. Many health and wellness stores, such as Walgreens Boots Alliance, CVS Health, and Rite Aid, now offer CBD-based products. CBD is a non-psychoactive compound found in the hemp plant and is used in various forms, such as cream, edibles, oils, and tinctures. It is marketed for its potential health benefits, such as reducing anxiety and pain. It has seen a surge in demand due to the increasing legalization and normalization of marijuana and hemp-based products.
Global Cannabidiol Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cannabidiol market report based on source type, sales type, end use, and region:
- Source Type Outlook (Revenue, USD Million, 2021 - 2033)
- Hemp
- Marijuana
- Sales Type Outlook (Revenue, USD Million, 2021 - 2033)
- B2B
- By End Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End Use
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Medical
- Chronic Pain
- Mental Disorders
- Cancer
- Others
- Personal Use
- Pharmaceuticals
- Wellness
- Food & Beverages
- Personal Care & Cosmetics
- Nutraceuticals
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Netherlands
- Switzerland
- Italy
- France
- Poland
- Czech Republic
- Croatia
- Asia Pacific
- China
- India
- South Korea
- Japan
- New Zealand
- Australia
- Latin America
- Argentina
- Brazil
- Mexico
- Colombia
- Uruguay
- Chile
- Middle East & Africa (MEA)
- Israel
- South Africa
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Site
- 1.2.3. Application
- 1.2.4. Grade type
- 1.2.5. Distribution channel
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Site outlook
- 2.2.3. Application outlook
- 2.2.4. Grade type outlook
- 2.2.5. Distribution channel
- 2.3. Competitive Insights
- Chapter 3. China Wearable Medical Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising demand for round-the-clock monitoring
- 3.2.1.2. Growing awareness on fitness
- 3.2.1.3. Technological advancements
- 3.2.1.4. Growing prevalence of chronic diseases
- 3.2.1.5. Growing geriatric population
- 3.2.2. Market Restraint Impact Analysis
- 3.2.2.1. Data security and privacy issues
- 3.2.2.2. Non-availability of reimbursement
- 3.2.3. Market Opportunity Impact Analysis
- 3.2.3.1. Increasing home healthcare services
- 3.2.3.2. Expansion into emerging markets
- 3.2.3.3. Growing number of clinical trials
- 3.2.3.4. Rising government initiatives for digital healthcare
- 3.2.4. Market Challenge Impact Analysis
- 3.2.4.1. Product recalls
- 3.3. China Wearable Medical Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Reimbursement Scenario
- Chapter 4. China Wearable Medical Devices Market: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2025 & 2033
- 4.2. Segment Dashboard
- 4.3. China Wearable Medical Devices Market by Product Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.4.1. Diagnostic Devices
- 4.4.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 4.4.1.2. Vital Sign Monitor
- 4.4.1.2.1. Vital sign monitor market, 2021 - 2033 (USD Million)
- 4.4.1.2.2. Heart Rate Monitors
- 4.4.1.2.2.1. Heart rate monitors market, 2021 - 2033 (USD Million)
- 4.4.1.2.3. Activity Monitors
- 4.4.1.2.3.1. Activity monitors market, 2021 - 2033 (USD Million)
- 4.4.1.2.4. Electrocardiographs
- 4.4.1.2.4.1. Electrocardiographs market, 2021 - 2033 (USD Million)
- 4.4.1.2.5. Pulse Oximeters
- 4.4.1.2.5.1. Pulse oximeters market, 2021 - 2033 (USD Million)
- 4.4.1.2.6. Spirometers
- 4.4.1.2.6.1. Spirometers market, 2021 - 2033 (USD Million)
- 4.4.1.2.7. Blood Pressure Monitors
- 4.4.1.2.7.1. Blood pressure monitors market, 2021 - 2033 (USD Million)
- 4.4.1.2.8. Others
- 4.4.1.2.8.1. Others market, 2021 - 2033 (USD Million)
- 4.4.1.3. Sleep Monitoring Device
- 4.4.1.3.1. Sleep monitoring device market, 2021 - 2033 (USD Million)
- 4.4.1.3.2. Sleep Trackers
- 4.4.1.3.2.1. Sleep trackers market, 2021 - 2033 (USD Million)
- 4.4.1.3.3. Wrist Actigraphs
- 4.4.1.3.3.1. Wrist actigraphs market, 2021 - 2033 (USD Million)
- 4.4.1.3.4. Polysomnographs
- 4.4.1.3.4.1. Polysomnographs market, 2021 - 2033 (USD Million)
- 4.4.1.3.5. Others
- 4.4.1.3.5.1. Others market, 2021 - 2033 (USD Million)
- 4.4.1.4. Electrocardiographs Fetal & Obstetric Devices
- 4.4.1.4.1. Electrocardiographs fetal & obstetric devices market, 2021 - 2033 (USD Million)
- 4.4.1.5. Neuromonitoring Devices
- 4.4.1.5.1. Neuromonitoring devices market, 2021 - 2033 (USD Million)
- 4.4.1.5.1.1. EEG (Electroencephalographs)
- 4.4.1.5.1.1.1. EEG market, 2021 - 2033 (USD Million)
- 4.4.1.5.1.2. EMG (Electromyography)
- 4.4.1.5.1.2.1. EMG market, 2021 - 2033 (USD Million)
- 4.4.1.5.1.3. Others
- 4.4.1.5.1.3.1. Others market, 2021 - 2033 (USD Million)
- 4.4.2. Therapeutic Devices
- 4.4.2.1. Therapeutic Device Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.2.2. Pain Management Devices
- 4.4.2.2.1. Pain management devices market, 2021 - 2033 (USD Million)
- 4.4.2.2.2. Neurostimulation Devices
- 4.4.2.2.2.1. Neurostimulation devices market, 2021 - 2033 (USD Million)
- 4.4.2.2.3. Others
- 4.4.2.2.3.1. Others market, 2021 - 2033 (USD Million)
- 4.4.2.3. Insulin Monitoring Devices
- 4.4.2.3.1. Insulin monitoring devices market, 2021 - 2033 (USD Million)
- 4.4.2.3.2. Insulin Pumps
- 4.4.2.3.2.1. Insulin pumps market, 2021 - 2033 (USD Million)
- 4.4.2.3.3. Others
- 4.4.2.3.3.1. Others market, 2021 - 2033 (USD Million)
- 4.4.2.3.3.2. Autoinjectors
- 4.4.2.3.3.2.1. Autoinjectors market, 2021 - 2033 (USD Million)
- 4.4.2.3.3.3. Others
- 4.4.2.3.3.3.1. Others market, 2021 - 2033 (USD Million)
- 4.4.2.4. Rehabilitation Devices
- 4.4.2.4.1. Rehabilitation devices market, 2021 - 2033 (USD Million)
- 4.4.2.4.2. Accelerometers
- 4.4.2.4.2.1. Accelerometers market, 2021 - 2033 (USD Million)
- 4.4.2.4.3. Sensing Devices
- 4.4.2.4.3.1. Sensing devices market, 2021 - 2033 (USD Million)
- 4.4.2.4.4. Ultrasound Platform
- 4.4.2.4.4.1. Ultrasound platform market, 2021 - 2033 (USD Million)
- 4.4.2.4.5. Others
- 4.4.2.4.5.1. Others market, 2021 - 2033 (USD Million)
- 4.4.2.5. Respiratory Therapy Devices
- 4.4.2.5.1. Respiratory therapy devices market, 2021 - 2033 (USD Million)
- 4.4.2.5.2. Ventilators
- 4.4.2.5.2.1. Ventilators market, 2021 - 2033 (USD Million)
- 4.4.2.5.3. CPAP
- 4.4.2.5.3.1. CPAP market, 2021 - 2033 (USD Million)
- 4.4.2.5.4. Portable Oxygen Concentrators
- 4.4.2.5.4.1. Portable oxygen concentrators market, 2021 - 2033 (USD Million)
- 4.4.2.5.5. Others
- 4.4.2.5.5.1. Others market, 2021 - 2033 (USD Million)
- Chapter 5. China Wearable Medical Devices Market: Site Estimates & Trend Analysis
- 5.1. Site Market Share, 2025 & 2033
- 5.2. Segment Dashboard
- 5.3. China Wearable Medical Devices Market by Site Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.4.1. Handheld
- 5.4.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.4.2. Headband
- 5.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.4.3. Strap/Clip/Bracelet
- 5.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.4.4. Shoe Sensors
- 5.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 5.4.5. Others
- 5.4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 6. China Wearable Medical Devices Market: Application Estimates & Trend Analysis
- 6.1. Application Market Share, 2025 & 2033
- 6.2. Segment Dashboard
- 6.3. China Wearable Medical Devices Market by Application Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.4.1. Sports & Fitness
- 6.4.1.1. Market estimates and forecasts, 2021 to 2033 (USD million)
- 6.4.2. Remote Patient Monitoring
- 6.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 6.4.3. Home Healthcare
- 6.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 7. China Wearable Medical Devices Market: Grade Type Estimates & Trend Analysis
- 7.1. Grade Type Market Share, 2025 & 2033
- 7.2. Segment Dashboard
- 7.3. China Wearable Medical Devices Market by Grade Type Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 7.4.1. Consumer-grade Wearable Medical Devices
- 7.4.1.1. Market estimates and forecasts, 2021 to 2033 (USD million)
- 7.4.2. Clinical Wearable Medical Devices
- 7.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 8. China Wearable Medical Devices Market: Distribution Channel Estimates & Trend Analysis
- 8.1. Distribution Channel Market Share, 2025 & 2033
- 8.2. Segment Dashboard
- 8.3. China Wearable Medical Devices Market by Distribution Channel Outlook
- 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 8.4.1. Pharmacy
- 8.4.1.1. Market estimates and forecasts, 2021 to 2033 (USD million)
- 8.4.2. Online Channels
- 8.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- 8.4.3. Hypermarkets
- 8.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company market share analysis, 2025
- 9.4. Company Profiles
- 9.4.1. CONTEC Medical Systems Co. Ltd.
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. Huawei Technologies Co., Ltd.
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Xiaomi
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Omron Corporation
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Abbott Laboratories Shanghai Co. Ltd. (Abbott)
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Medtronic
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. Apple, Inc.
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product benchmarking
- 9.4.7.4. Strategic initiatives
- 9.4.8. Alphabet Inc.
- 9.4.8.1. Company overview
- 9.4.8.2. Financial performance
- 9.4.8.3. Product benchmarking
- 9.4.8.4. Strategic initiatives
- 9.4.9. Cortivision
- 9.4.9.1. Company overview
- 9.4.9.2. Financial performance
- 9.4.9.3. Product benchmarking
- 9.4.9.4. Strategic initiatives
- 9.4.10. Tekscan, Inc.
- 9.4.10.1. Company overview
- 9.4.10.2. Financial performance
- 9.4.10.3. Product benchmarking
- 9.4.10.4. Strategic initiatives
- 9.4.11. Koninklijke Philips N.V.
- 9.4.11.1. Company overview
- 9.4.11.2. Financial performance
- 9.4.11.3. Product benchmarking
- 9.4.11.4. Strategic initiatives
- 9.4.12. GE HealthCare
- 9.4.12.1. Company overview
- 9.4.12.2. Financial performance
- 9.4.12.3. Product benchmarking
- 9.4.12.4. Strategic initiatives
- 9.4.13. Insulet Consulting (Shenzhen) Co., Ltd.
- 9.4.13.1. Company overview
- 9.4.13.2. Financial performance
- 9.4.13.3. Product benchmarking
- 9.4.13.4. Strategic initiatives
- 9.4.14. Samsung
- 9.4.14.1. Company overview
- 9.4.14.2. Financial performance
- 9.4.14.3. Product benchmarking
- 9.4.14.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
